DRW Securities’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$492K Buy
13,660
+7,697
+129% +$259K 0.01% 437
2026
Q1
$214K Buy
+5,963
New +$154K ﹤0.01% 1073
2025
Q3
– Sell
-12,236
Closed -$193K – 1334
2025
Q2
$193K Sell
12,236
-31,524
-72% -$401K ﹤0.01% 972
2025
Q1
$555K Sell
43,760
-79,182
-64% -$1.24M 0.02% 329
2024
Q4
$2.71M Buy
122,942
+1,841
+2% +$38.7K 0.09% 130
2024
Q3
$2.16M Buy
121,101
+65,145
+116% +$1.04M 0.06% 163
2024
Q2
$898K Buy
+55,956
New +$883K 0.04% 255

Other funds holding CLMT

DRW Securities's CLMT Position: Q2 2026 in Review

DRW Securities increased its Calumet Specialty Products (CLMT) stake by 129% in Q2 2026, buying an estimated $259K and bringing the position to 13,660 shares worth $492K. The position accounts for 0.01% of the portfolio, ranked #437.

DRW Securities first reported a position in CLMT in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.71M in Q4 2024. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • DRW Securities held 13,660 shares of Calumet Specialty Products worth $492K as of Q2 2026.
  • DRW Securities bought 7,697 Calumet Specialty Products shares in Q2 2026, an estimated $259K.
  • Calumet Specialty Products made up 0.01% of DRW Securities's portfolio in Q2 2026, its #437 holding.
  • DRW Securities first reported a position in Calumet Specialty Products in Q2 2024 and has held it in 7 quarters since.
  • DRW Securities's Calumet Specialty Products position peaked at $2.71M in Q4 2024.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.